Much clinical evidence suggests that higher circulating C-reactive protein (CRP) [26] and neutrophil–lymphocyte ratios (NLRs) [27] in IS are associated with an increased sICH risk and worse outcomes and are inflammatory indices for AIS patients. This evidence concerns the gene CRP and androgen insensitivity syndrome.